US Patent

US11786548 — Trace element compositions, methods of making and use

Formulation · Assigned to American Regent Inc · Expires 2041-07-01 · 15y remaining

Vulnerability score 50/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a stable injectable composition for parenteral nutrition that includes water and specific amounts of zinc, copper, selenium, or manganese per milliliter.

USPTO Abstract

Injectable compositions that can be added to parenteral nutrition are provided. In particular, a stable injectable composition is provided which includes water, and at least one of about 800 μg to about 4,000 μg of zinc, about 40 μg to about 400 μg of copper, from about 4 μg to about 90 μg of selenium, or from about 1 μg to about 80 μg of manganese per 1 mL of the injectable composition. Methods of preparing and using of the stable injectable composition are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
US11786548
Jurisdiction
US
Classification
Formulation
Expires
2041-07-01
Drug substance claim
No
Drug product claim
Yes
Assignee
American Regent Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.